Oscar Health Announces Strong Results for Fourth Quarter and Full Year 2023; Introduces Full Year 2024 Outlook Including Total Company Adjusted EBITDA Profitability

Go back to Oscar Health Announces Strong Results for Fourth Quarter and Full Year 2023; Introduces Full Year 2024 Outlook Including Total Company Adjusted EBITDA Profitability

Oscar Health (OSCR) rockets 22% on narrower Q4 loss and impressive 2024 guidance

February 8, 2024 4:39 AM EST

Shares of Oscar Health (NYSE: OSCR) surged 22% in premarket trading Thursday after the health insurer reported a narrower-than-expected Q4 loss and issued an upbeat EBITDA guidance for 2024.

The company posted a fourth-quarter loss per share of $0.66, less than the anticipated loss of $0.72. Revenue came in at $1.43... More